G Klein|H Matthys - JoVE Visualize

Showing results (701-710 of 1,907) with videos related to

Pageof 191

Sort By:

Klinische Padiatrie|April 24, 2004

[Osteogenesis imperfecta Type 1: a case presentation with a new mutation in gene COL1A1]T Siegert, H-G Klein, C Marschall, et al.

Journal of the National Cancer Institute|October 1, 1975

Dynamic alterations in some surface properties of freshly explanted Moloney lymphoma cellsM Ran, I Eshel, I P Witz, et al.

Mutation Research|December 5, 1998

Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of BigBlue rats and Muta Mouse mice in vivo after inhalationC Mayer, R G Klein, H Wesch, et al.

Journal of the National Cancer Institute|January 1, 1975

Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cellsW Leibold, T D Flanagan, J Menezes, et al.

Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1994

Clonazepam in childhood anxiety disordersF Graae, J Milner, L Rizzotto, et al.

Arzneimittel-Forschung|June 1, 1986

Suprofen sustained release kinetics in healthy male volunteers. 2nd communication: a multiple dose steady-state kinetics of suprofen sustained release tablets during 6 days in healthy male volunteersN Michos, H W Zulliger, T Möller, et al.

British Journal of Cancer|December 19, 2001

Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsyE R Sauter, H Ehya, A Mammen, et al.

The Journal of Pathology|January 1, 1975

Genetic determinants of morphological differentiation in a lymphoma-sarcoma hybridA L Cochran, H Harris, F Wiener, et al.

Frontiers in Psychology|March 1, 2017

Disentangling the Common Variance of Perfectionistic Strivings and Perfectionistic Concerns: A Bifactor Model of PerfectionismJana C Gäde, Karin Schermelleh-Engel, Andreas G Klein

Arzneimittel-Forschung|January 1, 1980

[Testing the effectiveness of cerebrally active drugs. Preliminary communication on a test model for cerebrally active drugs in humans]H Maier-Lenz, L Ringwelski, G Klein, et al.

Pageof 191

Showing results (701-710 of 1,907) with videos related to

Sort By:

Pageof 191

Klinische Padiatrie|April 24, 2004

[Osteogenesis imperfecta Type 1: a case presentation with a new mutation in gene COL1A1]T Siegert, H-G Klein, C Marschall, et al.

Journal of the National Cancer Institute|October 1, 1975

Dynamic alterations in some surface properties of freshly explanted Moloney lymphoma cellsM Ran, I Eshel, I P Witz, et al.

Mutation Research|December 5, 1998

Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of BigBlue rats and Muta Mouse mice in vivo after inhalationC Mayer, R G Klein, H Wesch, et al.

Journal of the National Cancer Institute|January 1, 1975

Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cellsW Leibold, T D Flanagan, J Menezes, et al.

Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1994

Clonazepam in childhood anxiety disordersF Graae, J Milner, L Rizzotto, et al.

Arzneimittel-Forschung|June 1, 1986

Suprofen sustained release kinetics in healthy male volunteers. 2nd communication: a multiple dose steady-state kinetics of suprofen sustained release tablets during 6 days in healthy male volunteersN Michos, H W Zulliger, T Möller, et al.

British Journal of Cancer|December 19, 2001

Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsyE R Sauter, H Ehya, A Mammen, et al.

The Journal of Pathology|January 1, 1975

Genetic determinants of morphological differentiation in a lymphoma-sarcoma hybridA L Cochran, H Harris, F Wiener, et al.

Frontiers in Psychology|March 1, 2017

Disentangling the Common Variance of Perfectionistic Strivings and Perfectionistic Concerns: A Bifactor Model of PerfectionismJana C Gäde, Karin Schermelleh-Engel, Andreas G Klein

Arzneimittel-Forschung|January 1, 1980

[Testing the effectiveness of cerebrally active drugs. Preliminary communication on a test model for cerebrally active drugs in humans]H Maier-Lenz, L Ringwelski, G Klein, et al.

Pageof 191